Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced today an oversubscribed $93 million Series B financing round to accelerate the ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

The partnership will focus on early myopia detection, portable eye disease screening, and non-invasive diabetes monitoring ...